MOUNTAIN VIEW, Calif., Nov. 26, 2013 /PRNewswire/ -- Based on its recent analysis of the medical imaging market, Frost & Sullivan recognizes EOS imaging with the 2013 North America Frost & Sullivan Award for Product Innovation Leadership. The company's flagship product, the EOS, provides high-quality, whole-body images of a sitting or standing patient, using a fraction of the radiation dose required by conventional imaging methods. A unique modality with no direct competition in the market, the EOS is gradually establishing its presence in the orthopedic space, where it is finding application as a valuable diagnostic, as well as a pre- and post-surgical clinical tool.
The EOS system uses simultaneous image acquisition from two connected imaging assemblies, enabling intrinsic 3-D weight-bearing modeling of the bone envelope from just two views. It also captures frontal and lateral views, without stitching, in a single, low-dose imaging episode. Furthermore, the resulting images are true-size with a one-to-one scale, enabling accurate and reproducible measurements, intuitive interpretation and better-informed clinical insight.
The solution can acquire a full-body image of an adult patient in less than 20 seconds, of a pediatric patient in less than 15 seconds, and totals less than four minutes of exam time, even for the most complex procedures, such as spine imaging. These capabilities have resulted in a clinically effective, economically profitable, new imaging service line for providers.
"The fast and efficient workflow designed for the EOS leverages not only high-performance technology components, but also intelligent software and patient ergonomics," said Frost & Sullivan Principal Analyst Nadim Daher. "With a full-fledged, end-to-end clinical solution, including imaging equipment, clinical applications and associated services, the EOS system competes effectively with the gold standards—radiography, computed tomography (CT), and magnetic resonance (MR) imaging. A growing body of clinical research findings continues to establish strong evidence of the benefits of the EOS system with regard to its clinical value, the workflow it proposes, return on investment (ROI) model, and the low dose administered to patients."Compared to traditional radiography solutions, the competitively priced EOS system offers numerous avenues for revenue growth. The higher number of clinical procedures addressed by the EOS system, involving more clinical subspecialties, further boosts the ROI opportunity for providers, while generating synergies throughout the imaging enterprise.